Showing 1 - 10 of 17
Persistent link: https://www.econbiz.de/10010200106
We estimate a model of drug demand and supply that incorporates insurance, advertising, and competition between branded and generic drugs within and across therapeutic classes. We use data on antiulcer drugs from 1991 to 2010. Our simulations show generics and "me-too" drugs each increased...
Persistent link: https://www.econbiz.de/10010250679
Persistent link: https://www.econbiz.de/10011817199
Persistent link: https://www.econbiz.de/10012543521
Persistent link: https://www.econbiz.de/10011820436
Persistent link: https://www.econbiz.de/10011824105
Persistent link: https://www.econbiz.de/10011660322
Shortages and rationing are common in health care, yet we know little about the consequences. We examine an 18-month shortage of the pediatric Haemophilus Influenzae Type B (Hib) vaccine. Using insurance claims data and variation in shortage exposure across birth cohorts, we find that the...
Persistent link: https://www.econbiz.de/10014322866
Persistent link: https://www.econbiz.de/10014474713
<Emphasis Type="Bold">Objective: To estimate rates of non-adherence for statins following implementation of a preferred drug list (PDL). <Emphasis Type="Bold">Study design: A retrospective cohort study. <Emphasis Type="Bold">Methods: A difference-in-difference-in-difference approach was used to estimate the impact of a PDL on the use of statins in an Alabama...</emphasis></emphasis></emphasis>
Persistent link: https://www.econbiz.de/10011001628